---
title: "709 Healthtech Venture Capital Firms in the US (Nov 2026)"
last_updated: "2026-11-07"
rows: "709"
free_rows: "25"
source: "SEC Form D filings and our own research"
canonical: "https://theinvestordatabase.com/lists/healthtech-investors-us/"
---

# 709 healthtech venture capital firms in the US

We list 709 healthtech venture capital firms in the US as of November 2026: 704 have an SEC filing on file and 5 were checked on the firm's own website or an official register, and the list was last checked on 7 Nov 2026. The cities with the most head offices on this list are New York (81), San Francisco (67) and Palo Alto (39).

- 709 firms
- 383 with a fund filing or dated deal in the last 12 months
- $61M median fund size on file (SEC Form D, 504 firms)
- 3,509 named decision-makers on file

## First 25 of 709 healthtech venture capital firms in the US

| Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile |
|---|---|---|---|---|---|---|---|---|
| Khosla Ventures | VC firm | Menlo Park, CA | Pre-seed, Seed, Series A, Growth | Healthtech, AI, Consumer, B2B | New fund, Aug 2026 | $1.9B (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/khosla-ventures/ |
| NSV | VC firm | Greenwich, CT | Seed, Late stage | Healthtech, AI, Semiconductor, Mobility | Portfolio news, Oct 2026 | $990M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/nsv/ |
| Digitalis Ventures | VC firm | New York, NY | Seed | Healthtech, Biotech, Medtech | Portfolio news, Nov 2026 | $862M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/digitalis-ventures/ |
| Inspired | VC firm | New York, NY | Seed | Healthtech, AI, Fintech, Generalist | New fund, Oct 2026 | $450M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/inspired/ |
| New Science Ventures | VC firm | United States | Seed, Growth, Late stage | Healthtech, Deep Tech, AI, Semiconductor | Portfolio news, Oct 2026 | $1.0B (own site) | 2026-11-05 | https://theinvestordatabase.com/investors/new-science-ventures/ |
| Greycroft | VC firm | New York, NY | Series A, Series B, Growth | Healthtech, AI, Industrial Tech, Defense Tech | New deal, Oct 2026 | $600M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/greycroft/ |
| Safar Partners | VC firm | Cambridge, MA | Seed | Healthtech, Industrial Tech, Biotech, Deep Tech | New deal, Aug 2026 | $300M (SEC Form D, 2023) | 2026-11-04 | https://theinvestordatabase.com/investors/safar-partners/ |
| Bison Ventures | VC firm | San Francisco, CA | Pre-seed, Seed, Series A, Series B | Healthtech, AI, Energy, Biotech | New fund, Oct 2026 | $160M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/bison-ventures/ |
| Gore Range Capital | VC firm | Southlake, TX | Seed | Healthtech, Biotech, Medtech | New deal, Aug 2026 | $250M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/gore-range-capital/ |
| Left Lane Capital | VC firm | Brooklyn, NY |  | Healthtech, AI, Fintech, Logistics | New deal, Aug 2026 | $599M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/left-lane-capital/ |
| SR One | VC firm | Wayne, PA |  | Healthtech, Biotech | New fund, Sep 2026 | $600M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/sr-one/ |
| Alpha Partners | VC firm | New York, NY | Series B, Growth | Healthtech, AI, Developer Tools, Cybersecurity | New fund, Oct 2026 | $200M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/alpha-partners/ |
| New Stack | VC firm | Chicago, IL | Pre-seed, Seed | Healthtech, AI, Fintech, Industrial Tech | New fund, Sep 2026 | $125M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/new-stack/ |
| Translink Capital | VC firm | Palo Alto, CA | Seed, Series A, Series B | Healthtech, AI, Developer Tools, Mobility | New fund, Sep 2026 | $174M (SEC Form D, 2021) | 2026-11-05 | https://theinvestordatabase.com/investors/translink-capital/ |
| 8VC | VC firm | Austin, TX |  | Healthtech, Data, AI, Biotech | New deal, Oct 2026 | $400M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/8vc-austin-2/ |
| Grand Ventures | VC firm | Grand Rapids, MI | Seed | Healthtech, AI, Developer Tools, Fintech | New deal, Sep 2026 | $100M (SEC Form D, 2022) | 2026-11-05 | https://theinvestordatabase.com/investors/grand-ventures/ |
| Town Hall Ventures | VC firm | New York, NY | Growth | Healthtech, Impact, Medtech | New deal, Sep 2026 | $400M (SEC Form D, 2025) | 2026-11-05 | https://theinvestordatabase.com/investors/town-hall-ventures/ |
| SOSV | VC firm | United States | Pre-seed | Healthtech, Deep Tech, Climate Tech, Biotech | Portfolio news, Nov 2026 | $131M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/sosv/ |
| Narya | VC firm | Columbus, OH | Seed | Healthtech, Fintech, Biotech, Defense Tech | New fund, Sep 2026 | $200M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/narya/ |
| Frist Cressey Ventures | VC firm | Nashville, TN |  | Healthtech, Medtech | New deal, Oct 2026 | $400M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/frist-cressey-ventures/ |
| Hatteras Venture Partners | VC firm | Durham, NC | Seed | Healthtech, Biotech, Medtech | New fund, Oct 2026 | $250M (SEC Form D, 2023) | 2026-11-04 | https://theinvestordatabase.com/investors/hatteras-venture-partners/ |
| Mindset Consulting (US) | VC firm | San Francisco, CA | Seed, Series A | Healthtech, B2B, AI, Fintech | Portfolio news, Sep 2026 | $129M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/mindset-consulting-us/ |
| Flyover Capital | VC firm | Kansas City, MO | Seed, Series A | Healthtech, AI, Fintech, SaaS | New fund, Oct 2026 | $75M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/flyover-capital/ |
| Health Velocity Capital | VC firm | San Mateo, CA |  | Healthtech, SaaS, Medtech | New fund, Aug 2026 | $300M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/health-velocity-capital/ |
| Cybernetix Ventures | VC firm | Boston, MA | Pre-seed, Seed, Series A | Healthtech, Robotics, Industrial Tech, Logistics | New fund, Aug 2026 | $100M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/cybernetix-ventures/ |

You are seeing 25 of 709. The full list adds 684 more firms and 3,509 named decision-makers.

Get all 709 firms and 3,509 named contacts, $197, one-time: https://theinvestordatabase.com/buy/us
This page: https://theinvestordatabase.com/lists/healthtech-investors-us/

## Method and limits
- Source: 704 of the 709 rows carry an SEC filing (Form D or Form ADV). 707 of the 709 have a website we checked; the other 2 rest on the filing or register entry alone. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. This list holds VC firms, fund managers and corporate venture arms; accelerators and angel networks are in their own lists. Sector: the firm states healthtech and digital health as a focus on its own site, or we observed it in the firm's portfolio.
- Order: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Fill rates: Of 709 rows: stage 578, sector 709, fund size 638, website 707. In the paid file: named decision-makers on 679 rows, firm email on 249, LinkedIn page on 385, check size on 53.

## Questions
### How many healthtech venture capital firms in the US are there?
We list 709 as of November 2026. 383 of the 709 have a fund filing or a dated deal in the last 12 months. The cities with the most are New York (81), San Francisco (67) and Palo Alto (39).

### Which healthtech venture capital firms in the US raised a new fund in the last 12 months?
268 of the 709 have a fund filing dated in the last 12 months. The most recent on this list are Quiet Capital (Nov 2026), Branch Venture Partners (Nov 2026) and LightX Capital (Nov 2026).

### What is the typical fund size of healthtech venture capital firms in the US?
The median fund size on file for this list is $61M, across the 504 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 205 do not disclose a size there.

### Which stage do most healthtech venture capital firms in the US back?
Of the 578 with a stage on file, seed (434), pre-seed (218) and Series A (163). A firm can back more than one stage, and 131 rows have no stage on file yet.

### Where does the data on healthtech venture capital firms in the US come from and how often is it updated?
704 of the 709 rows have an SEC filing on file (Form D or Form ADV) and 5 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 7 Nov 2026 at the latest. The whole file is re-verified twice a year.

### Can I download the list of healthtech venture capital firms in the US as a spreadsheet?
Yes. The file holds all 709 rows in Excel and CSV, with 3,509 named decision-makers and 249 firm emails, for $197 one-time as part of US Complete. 25 rows are free on this page.